On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayJan 09, 2017 12:58 pm

NetworkNewsBreaks – Medical Marijuana, Inc. (MJNA) Reports Positive Data on CanChew Plus® CBD Gum by AXIM® Biotechnologies, Inc. (AXIM)

Shares of Medical Marijuana (OTC: MJNA) are ticking higher after the company said its major investment company, AXIM® Biotechnologies (OTC: AXIM), received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials as treatment for irritable bowel syndrome (IBS). The single dose study conducted to determine the concentration of CBD in the blood after chewing one CanChew Plus® Gum for 30 minutes showed positive results for the 30 mg dosage. This data will be used to determine the optimal concentration in the IBS patient trial. AXIM aims to provide a pharmaceutical…

Continue Reading

MondayJan 09, 2017 12:54 pm

NetworkNewsBreaks – DryShips, Inc. (NASDAQ: DRYS) Acquires Large Gas Carrier through Option Agreement; Delivery set for June 2017

DryShips (NASDAQ: DRYS) has exercised its first option under a previously announced option agreement to acquire one Very Large Gas Carrier (VLGC) currently under construction at Hyundai Heavy Industries (HHI) for a purchase price of $83.5 million. The VLGC will be employed on a fixed-rate time charter with five years’ firm duration to an oil major; the charterer has options to extend the firm employment period by up to three years. DryShips said it expects the total gross backlog associated with this time charter to be $54.0 million – or $92.7 million including the optional periods – with delivery of…

Continue Reading

FridayJan 06, 2017 1:50 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 6, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: RSPI 12.07% – News: To present at 9th Annual Biotech Showcase January 9 PSCR 8.42% – News: Details multi-year contract with Centers for Medicare and Medicaid Services TYMI 7.97% – News: Hires Shabnam Stanicky as clinical operations officer ARDM 4.75% – News: To present at 9th Annual Biotech Showcase January 9 FHCO 2.52%– News: Launches PREBOOST for premature ejaculation SGMO 3.62% – News: Changes name to Sangamo Therapeutics to reflect focus on clinical development of…

Continue Reading

FridayJan 06, 2017 1:45 pm

NetworkNewsBreaks – Revance Therapeutics, Inc. (NASDAQ: RVNC) Flags Clinical Milestones, Offers 2017 Financial Guidance

Revance Therapeutics (NASDAQ: RVNC) has three ongoing clinical trials of its RT002 injectable, the results of which the company says it will report by year-end. In a news release yesterday afternoon, the company also guided for 2017 cash burn between $102 million-$112 million; GAAP operating expense between $108 million-$119 million; and non-GAAP operating expense of $94 million-$102 million. R&D expense for 2017 is forecast in the range of $75 million-$83 million (GAAP), $69 million-$75 million (non-GAAP).  Revance’s cash and investments balance of $185 million, as of Dec. 31, 2016, is expected to fund operations into the third quarter of 2018.…

Continue Reading

FridayJan 06, 2017 1:43 pm

NetworkNewsBreaks – Zogenix, Inc. (NASDAQ: ZGNX) Names Biotech Veteran as New CFO

As part of its ongoing relocation of all corporate functions, Zogenix (NASDAQ: ZGNX) reports that Michael P. Smith will succeed the departing CFO, EVP and treasurer and secretary, Ann D. Rhoads. Rhoads will continue in her roles with Zogenix until January 16, 2017, at which point she will provide consulting services to help the company complete its 2016 year-end audit and related filings for the calendar year ended December 31, 2016. Smith brings to the table 18+ years of experience in senior executive roles at public and private biotechnology companies. He has also managed and led over $3 billion of transactions,…

Continue Reading

FridayJan 06, 2017 1:39 pm

NetworkNewsBreaks – Identiv, Inc. (NASDAQ: INVE), NXP Semiconductors (NASDAQ: NXPI) Partner to Provide Smart Badges for CES 2017

Identiv (NASDAQ: INVE), a provider of radio frequency ID (RFID) inlays, has partnered with NXP Semiconductors N.V. (NASDAQ: NXPI) to provide RFID-inlayed badges to the 170,000+ attendees of the ongoing CES 2017 tradeshow in Las Vegas. Identiv’s high-end high-quality inlay is designed exclusively for NXP’s MIFARE DESFire EV2 state-of-the-art platform. The combined technologies enable CES attendees to quickly and securely share contact details, as well as use their badge to get into events, ride the Las Vegas Monorail, and access bike-sharing services. “Together with NXP, we are bringing fast, reliable, and safe access and transportation to all attendees during the…

Continue Reading

FridayJan 06, 2017 1:36 pm

NetworkNewsBreaks – eMagin Corp. (NYSE: EMAN) Establishes Foundation for Strong 2017

eMagin (NYSE: EMAN) wrapped up a firm fourth quarter that demonstrated the company’s momentum heading into 2017. After launching two products in the final months of 2016, eMagin earlier this week said it will exhibit its products at CES 2017, an annual global consumer electronics and consumer technology tradeshow held this month in Las Vegas. By appointment, eMagin will showcase its highest brightness, direct patterned micro-displays designed for the virtual reality (VR) and augmented reality (AR) markets. The company’s award-winning BlazeSpark smartphone attachment and the BlazeTorch goggles will also be on display. “I am pleased to report we achieved what…

Continue Reading

ThursdayJan 05, 2017 2:36 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 5, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: CSEI 281.25% – News: Contracted to supply its PwrCor™ engine for clean energy project ETRM 93.30% – News: vBloc Neurometabolic Therapy available at MedStar Health, Roper St. Francis LEON 53.85% – News: Acquires Connecticut-based health care company, Sinol USA PIRS 23.14% – News: Forms collaboration with Servier, an independent international pharmaceutical company PAYD 22.91%– News: Signs merger agreement with emergeIT, Inc. to create new global ecommerce and shipping platform FCSC 23.46% – News: FDA…

Continue Reading

ThursdayJan 05, 2017 1:56 pm

NetworkNewsBreaks – Heron Therapeutics, Inc. (NASDAQ: HRTX) – Financials Outweigh Positive HTX-011 Data

Shares of Heron Therapeutics (NASDAQ: HRTX) tumbled from yesterday’s rally after its Q4 Sustol sales results and FY2017 guidance overshadowed separately reported data from phase 2 studies of HTX-011 in patients undergoing bunionectomy (Study 208) and abdominoplasty (Study 203). In a filing, Heron reported Q4 sales of Sustol at $1.1 million and full-year sales of $15 million-$25 million, short of analyst estimates for $2.1 million and $48.8 million, respectively. Regarding the studies: Heron said the results of Study 208 demonstrate statistically significant synergy between the local anesthetic bupivacaine and the anti-inflammatory meloxicam in HTX-011, an extended-release combination product for the…

Continue Reading

ThursdayJan 05, 2017 1:45 pm

NetworkNewsBreaks – Cytori (NASDAQ: CYTX) Continues to Advance Cytori Cell Therapy Clinical Trial

Cytori Therapeutics (NASDAQ: CYTX) continues to move forward with its Cytori Cell Therapy™ program, and in mid-December enrolled and treated more than half of the 45 patients in its ADRESU trial in Japan to study the efficacy and safety of Cytori Cell Therapy™ in men with stress urinary incontinence after prostatic intervention for prostate cancer or benign prostatic hypertrophy. Cytori Cell Therapy™ is being developed as a therapy to be delivered in a single treatment, designed to avoid the need for frequent re-treatment. The company reports that the therapy has thus far been well-tolerated and that it expects full enrollment…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217